AGN vs COV

ASX Healthcare sector comparison — updated 24 Jul 2026 — Healthcare sector

AGN

ARGENICA FPO [AGN]

42LOW

COV

CLEO DIAGN FPO [COV]

46LOW

Score Breakdown

AGN COV
Technical
54
42
Catalyst
53
50
Sentiment
50
50
Fundamental
34
68
Momentum
22
64
Risk Gate
42
46

Key Metrics

AGN Metric COV
$19.3MMarket Cap$50.0M
369KAvg Volume (20d)262K
N/AShort InterestN/A
$0.77052-Week High$0.900
$0.08752-Week Low$0.335
-3.2%Daily Change-1.4%
$0.150Reference Price$0.350
-117.8%ROE-49.6%
N/AProfit Margin-157.4%

Active Signals

AGN Signals

Trading above both moving averages — the trend is your friend here
Drifting lower — down 6.2% over the last 5 days
Beating the Small Ords index — relative strength of 1.65, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Revenue in sharp decline (-78%)
Piotroski F-Score weak (3/9, low-confidence approx)
Near 52-week low (9% of range)

COV Signals

RSI is looking oversold — historically a spot where stocks tend to bounce
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Volume surging at 3.5x normal while price falls — heavy selling pressure
Lagging the Small Ords index — relative strength of 0.76, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (15 quarters)
Strong revenue growth (+373%)

Ask Scout AI to compare AGN and COV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AGN vs EBO →AGN vs EBR →AGN vs ECS →AGN vs EIQ →AGN vs GSS →
AGN Full Analysis → COV Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).